Literature DB >> 28219517

Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761).

Mark C Gillies1, Vincent Daien2, Vuong Nguyen1, Daniel Barthelmes3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28219517     DOI: 10.1016/j.ophtha.2016.05.054

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  2 in total

1.  miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1.

Authors:  Ming Fang; Yanfei Li; Yingbiao Wu; Zhongping Ning; Xuejun Wang; Xinming Li
Journal:  Cell Cycle       Date:  2019-03-20       Impact factor: 4.534

Review 2.  Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry.

Authors:  Vuong Nguyen; Daniel Barthelmes; Mark C Gillies
Journal:  Clin Exp Ophthalmol       Date:  2021-06-21       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.